Wordt geladen...
Use and effectiveness of pegfilgrastim prophylaxis in US clinical practice:a retrospective observational study
BACKGROUND: Febrile neutropenia (FN) is a serious complication of myelosuppressive chemotherapy. Clinical practice guidelines recommend routine prophylactic coverage with granulocyte colony-stimulating factor (G-CSF)—such as pegfilgrastim—for most patients receiving chemotherapy with an intermediate...
Bewaard in:
| Gepubliceerd in: | BMC Cancer |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6688232/ https://ncbi.nlm.nih.gov/pubmed/31399079 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6010-9 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|